| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 医药制造儿童类药(元) | 282,266,264.59 | 561,152,059.13 | 356,805,481.68 | 936,348,576.73 | 502,058,078.36 |
| 医药制造慢性病类药(元) | 133,051,549.31 | 242,190,610.57 | 132,568,306.49 | 369,920,397.64 | 316,847,912.45 |
| 医药其他及服务(元) | - | 35,293,966.36 | - | 46,687,950.02 | - |
| 医药制造其他类药(元) | - | 93,633,908.18 | - | - | - |
| 其他(元) | 76,400,412.67 | - | 94,424,310.99 | 97,273,370.89 | 93,618,929.17 |
| 营业成本(元) | |||||
| 医药制造儿童类药(元) | 54,687,768.54 | 130,620,255.54 | 77,703,253.92 | 249,261,632.37 | 87,967,491.13 |
| 医药制造慢性病类药(元) | 108,367,724.05 | 191,531,778.97 | 108,048,579.86 | 227,134,992.74 | 103,833,726.22 |
| 医药其他及服务(元) | - | 23,494,436.41 | - | - | - |
| 医药制造其他类药(元) | - | 60,108,661.27 | - | - | - |
| 其他(元) | 46,231,337.19 | - | 57,799,885.80 | - | 61,240,347.01 |
| 毛利(元) | |||||
| 医药制造儿童类药(元) | 227,578,496.05 | 430,531,803.59 | 279,102,227.76 | 687,086,944.36 | 414,090,587.23 |
| 医药制造慢性病类药(元) | 24,683,825.26 | 50,658,831.60 | 24,519,726.63 | 142,785,404.90 | 213,014,186.23 |
| 医药其他及服务(元) | - | 11,799,529.95 | - | - | - |
| 医药制造其他类药(元) | - | 33,525,246.91 | - | - | - |
| 其他(元) | 30,169,075.48 | - | 36,624,425.19 | - | 32,378,582.16 |
| 毛利率(%) | |||||
| 医药制造儿童类药(%) | 80.63 | 76.72 | 78.22 | 73.38 | 82.48 |
| 医药制造慢性病类药(%) | 18.55 | 20.92 | 18.50 | 38.60 | 67.23 |
| 医药其他及服务(%) | - | 33.43 | - | - | - |
| 医药制造其他类药(%) | - | 35.80 | - | - | - |
| 其他(%) | 39.49 | - | 38.79 | - | 34.59 |
| 收入构成(%) | |||||
| 医药制造儿童类药(%) | 57.40 | 60.19 | 61.12 | 64.57 | 55.02 |
| 医药制造慢性病类药(%) | 27.06 | 25.98 | 22.71 | 25.51 | 34.72 |
| 医药其他及服务(%) | - | 3.79 | - | 3.22 | - |
| 医药制造其他类药(%) | - | 10.04 | - | - | - |
| 其他(%) | 15.54 | - | 16.17 | 6.71 | 10.26 |
| 毛利构成(%) | |||||
| 医药制造儿童类药(%) | 80.58 | 81.77 | 82.03 | 82.79 | 62.79 |
| 医药制造慢性病类药(%) | 8.74 | 9.62 | 7.21 | 17.21 | 32.30 |
| 医药其他及服务(%) | - | 2.24 | - | 0.00 | - |
| 医药制造其他类药(%) | - | 6.37 | - | - | - |
| 其他(%) | 10.68 | - | 10.76 | 0.00 | 4.91 |